ACOG Clinical Consensus No. 10: Cannabis Use During Pregnancy and Lactation

Cannabis refers to all products derived from the plants Cannabis sativa, Cannabis indica, and Cannabis ruderalis and is the most commonly used illicit drug under U.S. federal law. With increasing social acceptability, accessibility, and legalization in many states, the prevalence of cannabis use among pregnant and lactating individuals has increased significantly. Substance use in pregnancy, including cannabis use, has been associated with adverse outcomes such as spontaneous preterm birth, low birth weight, and developmental delay. Obstetrician-gynecologists and other obstetric health care professionals should be aware of the possibility of pregnant and lactating patients' use of cannabis and be prepared to counsel and screen all patients and use evidence-based strategies to reduce cannabis use.

Publication Details

Journal
Obstetrics and Gynecology
Published
2025-09-18
DOI
https://doi.org/10.1097/aog.0000000000006053
Citations
8
Primary Topic
Prenatal Substance Exposure Effects
Type
article
Field-Weighted Citation Impact
27.95
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ACOG Clinical Consensus No. 10: Cannabis Use During Pregnancy and Lactation

8 citations
Obstetrics and Gynecology
Prenatal Substance Exposure Effects
27.95
article

ACOG Clinical Consensus No. 10: Cannabis Use During Pregnancy and Lactation

article en
8 citations

Abstract

Cannabis refers to all products derived from the plants Cannabis sativa, Cannabis indica, and Cannabis ruderalis and is the most commonly used illicit drug under U.S. federal law. With increasing social acceptability, accessibility, and legalization in many states, the prevalence of cannabis use among pregnant and lactating individuals has increased significantly. Substance use in pregnancy, including cannabis use, has been associated with adverse outcomes such as spontaneous preterm birth, low birth weight, and developmental delay. Obstetrician-gynecologists and other obstetric health care professionals should be aware of the possibility of pregnant and lactating patients' use of cannabis and be prepared to counsel and screen all patients and use evidence-based strategies to reduce cannabis use.

Obstetrics and GynecologyVol. 146(4)
Openalex Percentile: Top 0%
Prenatal Substance Exposure Effects
27.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.